Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Early cognitive changes linked to white matter damage in Parkinson’s

Subtle changes in white matter integrity are detectable in patients with Parkinson’s disease and are associated with early impairments in cognition, say researchers.

6 Aug 2015

DBS may aid cortical plasticity in Parkinson’s patients

Deep-brain stimulation of the subthalamic nucleus may help to restore long-term potentiation-like plasticity in the motor cortex of patients with Parkinson’s disease, a study shows.

4 Aug 2015

Research finding could help reveal how the human brain learns complex motor skills

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. To learn and improve, the songbird brain needs to shake up its tried-and-true patterns with a healthy dose of creative experimentation. Until now, no one has found a specific mechanism by which this could occur.

4 Aug 2015

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Scientists at The New York Stem Cell Foundation Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells.

4 Aug 2015

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells.

3 Aug 2015

Study sheds light on certain antagonist drugs that block physiological responses

Members of the Consolidated Research Group of Molecular Neurobiology of the Department of Biochemistry and Molecular Biology of the University of Barcelona (UB), affiliated with the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), have published a study in the journal Proceedings of the National Academy of Sciences (PNAS) about the formation of G protein-coupled receptors (GPCRs) which allows understanding the unexpected behaviour of some antagonists that block physiological responses.

30 Jul 2015

Study reveals new way to help medical students learn about Alzheimer's disease

With the growing number of people with Alzheimer's disease, understanding their care is vital for doctors. Yet medical students often just learn the facts and may only see people with advanced disease who are at the hospital or nursing home. A study shows a new way to help medical students learn about the disease—at the art museum.

30 Jul 2015

Study could pave way for more targeted treatments for individuals with brain disorders

Like Duke Ellington's 1931 jazz standard, the human brain improvises while its rhythm section keeps up a steady beat. But when it comes to taking on intellectually challenging tasks, groups of neurons tune in to one another for a fraction of a second and harmonize, then go back to improvising, according to new research led by UC Berkeley.

29 Jul 2015

Sham-controlled trial of deep brain stimulation treatment for depression fails to show efficacy

Depression is a leading cause of disability worldwide, and treatment-resistant symptoms of depression have a terrible personal and societal cost. They can devastate lives, careers, and families. Some severely ill patients may be unable to attend to even the basic elements of self-care, while others attempt or complete suicide.

29 Jul 2015

Lidocaine benefits breast cancer survivors who experience pain during intercourse

Scientists at Oregon Health & Science University report that breast cancer survivors who experience pain during sexual intercourse, a common side effect of breast cancer treatment, may achieve comfort when liquid lidocaine is applied strategically to prevent pain.

28 Jul 2015

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

Scientists from the Florida campus of The Scripps Research Institute have been awarded nearly $1.5 million from the National Institute of General Medical Sciences of the National Institutes of Health to explore the therapeutic potential of a class of proteins that play essential roles in the regulation and maintenance of human health.

28 Jul 2015

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

Low-dose lithium reduced involuntary motor movements - the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) - in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, degenerative condition.

28 Jul 2015

New research shows concussion may affect men and women differently

New research suggests concussion may not significantly impair symptoms or cognitive skills for one gender over another, however, women may still experience greater symptoms and poorer cognitive performance at preseason testing.

25 Jul 2015

Migraines may increase risk of stroke among smokers

New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published in the July 22, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Jul 2015

Study shows glitazone antidiabetic drug may reduce risk of Parkinson’s disease

A type of drug used to treat diabetes may reduce the risk of developing Parkinson’s disease, according to a new study published in PLOS Medicine.

22 Jul 2015

New approach holds great promise for developing effective treatments for human mitochondrial diseases

Using existing drugs, such as lithium, to restore basic biological processes in human cells and animal models, researchers may have broken a long-standing logjam in devising effective treatments for human mitochondrial diseases.

21 Jul 2015

New monoclonal antibodies may provide blueprint for effective Alzheimer's disease treatments

Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.

21 Jul 2015

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N Diagnostics and AbbVie today announced that the U.S. Food and Drug Administration has granted their investigational recombinant humanized anti-tau antibody, C2N-8E12 (ABBV-8E12), an orphan drug designation for the treatment of progressive supranuclear palsy (PSP).

17 Jul 2015

New pilot study suggests new era of clinical research in Parkinson's disease

A new pilot study in Parkinson's disease suggests a new era of clinical research which removes the barrier of distance for both scientists and volunteers. The research, which appears in the journal Digital Health, could also enable researchers to leverage the rapid growth in personal genetic testing to better diagnose, and potentially treat, a wide range of diseases.

17 Jul 2015

Neuroscientists interpret code the brain uses to make noisy neuronal circuits

By analyzing the signals of individual neurons in animals undergoing behavioral tests, neuroscientists at Rice University, Baylor College of Medicine, the University of Geneva and the University of Rochester have deciphered the code the brain uses to make the most of its inherently "noisy" neuronal circuits.

17 Jul 2015

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Early cognitive changes linked to white matter damage in Parkinson’s

DBS may aid cortical plasticity in Parkinson’s patients

Research finding could help reveal how the human brain learns complex motor skills

NYSCF scientists design new robotic platform to automate generation of patient-specific stem cells

Atomic level images reveal how neuropeptide hormone neurotensin may activate its receptors

Study sheds light on certain antagonist drugs that block physiological responses

Study reveals new way to help medical students learn about Alzheimer's disease

Study could pave way for more targeted treatments for individuals with brain disorders

Sham-controlled trial of deep brain stimulation treatment for depression fails to show efficacy

Lidocaine benefits breast cancer survivors who experience pain during intercourse

TSRI scientists awarded grant to explore therapeutic potential of protein receptors in Parkinson's disease, other disorders

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

New research shows concussion may affect men and women differently

Migraines may increase risk of stroke among smokers

Study shows glitazone antidiabetic drug may reduce risk of Parkinson’s disease

New approach holds great promise for developing effective treatments for human mitochondrial diseases

New monoclonal antibodies may provide blueprint for effective Alzheimer's disease treatments

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

New pilot study suggests new era of clinical research in Parkinson's disease

Neuroscientists interpret code the brain uses to make noisy neuronal circuits

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in